Altered gut microbiota profile in patients with generalized anxiety disorder/Experiment 2

From BugSigDB


Reviewed Marked as Reviewed by Shaimaa Elsafoury on 2021/02/09

Curated date: 2021/01/10

Curator: WikiWorks

Revision editor(s): WikiWorks

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Anxiety disorder anxiety,anxiety disorder,anxiety disorders,anxiety neuroses,anxiety neurosis,anxiety state,anxiety/mood disorders,chronic stress,mood and anxiety disorder,mood and anxiety disorders,neurotic anxiety states,Anxiety disorder
Group 0 name Corresponds to the control (unexposed) group for case-control studies
healthy controls
Group 1 name Corresponds to the case (exposed) group for case-control studies
treatment naiive Generalized Anxiety disorder
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
The active state of GAD was defined as a baseline Hamilton Anxiety Rating Scale HAMA score ≥14 upon admission to the hospital. The remissive state was defined as a HAMA score < 7 after 3 months of treatment.
Group 0 sample size Number of subjects in the control (unexposed) group
17
Group 1 sample size Number of subjects in the case (exposed) group
12
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
2 months

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
2
Matched on Factors on which subjects have been matched on in a case-control study
age, sex, body mass index

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
decreased
Chao1 Abundance-based estimator of species richness
decreased
Richness Number of species
decreased

Signature 1

Reviewed Marked as Reviewed by Shaimaa Elsafoury on 2021/02/09

Curated date: 2021/01/10

Curator: Shaimaa Elsafoury

Revision editor(s): WikiWorks

Source: Figure 2

Description: Comparison of relative abundance at the bacterial phylum and genus levels between healthy controls and treatment naiive generalized anxiety disorder groups

Abundance in Group 1: increased abundance in treatment naiive Generalized Anxiety disorder

NCBI Quality ControlLinks
Lactobacillus
Fusobacterium
Mediterraneibacter gnavus
Bacteroides
Escherichia
Shigella
Bacteroidaceae
Bacteroidales
Bacteroidia
Bacteroidota
Enterobacteriaceae
Enterobacterales
Parabacteroides
Lactobacillaceae
Thomasclavelia
[Ruminococcus] torques
[Clostridium] innocuum
Flavonifractor
Fusobacteriaceae
Fusobacteriales
Fusobacteriia
Fusobacteriota

Revision editor(s): WikiWorks

Signature 2

Reviewed Marked as Reviewed by Fatima on 2021/07/28

Curated date: 2021/01/10

Curator: Shaimaa Elsafoury

Revision editor(s): Fatima, WikiWorks

Source: Figure 2

Description: Comparison of relative abundance at the bacterial phylum and genus levels between healthy controls and treatment naiive generalized anxiety disorder groups

Abundance in Group 1: decreased abundance in treatment naiive Generalized Anxiety disorder

NCBI Quality ControlLinks
Anaerotruncus
Barnesiella
Butyricicoccus
Butyricimonas
Christensenellaceae
Clostridia
Collinsella
Coriobacteriaceae
Coriobacteriales
Eubacteriales
Eubacterium coprostanoligenes
Eubacterium ruminantium
Eubacterium xylanophilum
Faecalibacterium
Bacillota
Fusicatenibacter
Lachnospira
Lachnospira eligens
Lachnospiraceae
Moryella
Oscillospiraceae
Oxalobacter
Oxalobacteraceae
Parasutterella
Peptococcaceae
Peptococcus
Prevotellaceae
Roseburia
Ruminococcus gauvreauii
Subdoligranulum
Agathobacter rectalis

Revision editor(s): Fatima, WikiWorks